do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Comparison of and Can patients take GLP-1 and
Description
Finally, although the risk of bias was generally low across studies, sponsorship bias cannot be ruled out given that a substantial proportion of the included RCTs were industry-funded
These hormones are secreted from intestinal mucosal cells, and GLP-1 can be detected in the circulation minutes after oral ingestion of nutrients
Cell, 153(6), 11941217
Tirzepatide is the active ingredient in Zepbound, a GLP-1 receptor agonist
doi: 10.1016/S0140-6736(19)31149-3 16 GiuglianoD.MaiorinoM
failed to detect an effect of GLP1 on food intake [8]
